BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Oncopeptides AB: Year-end Report 2018

  At the company’s Capital Markets Day in December, an updated strategy for Oncopeptides’ business was presented

  February 22, 2019

   · 

  3 min read
• Novostia Technology for Heart Valve Prosthesis Raises CHF 6.5 Million to Start First Clinical Trials

  Novostia announces that it raised CHF 6.5 million from private investors to advance its disruptive aortic and mitral heart valve to clinical trials.

  February 22, 2019

   · 

  1 min read
• Business

  Lays Pain Oil Spray Available on Amazon

  Marshalls Traditional Healthcare product helps people soothe pains naturally

  February 22, 2019

   · 

  1 min read
• Pharm Country

  Mylan Launches Generic Suboxone® Sublingual Film to Treat Opioid Dependence

  Global pharmaceutical company Mylan N.V. announced the U.S. launch of Buprenorphine and Naloxone Sublingual Film, 8 mg/2 mg and 12 mg/3 mg, a generic version of Indivior’s Suboxone® Sublingual Film.

  February 22, 2019

   · 

  2 min read
• Deals

  Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Second Quarter Ended January 31, 2019

  CANTEL MEDICAL CORP. will release the results for its second quarter ended January 31, 2019 on Thursday, February 28, 2019 before the market opens, and hold a conference call to discuss the results at 9:30 a.m. ET.

  February 22, 2019

   · 

  1 min read
• Lone Star Bio

  The National Committee for Quality Assurance (NCQA) Certifies Jiva for 10 HEDIS® 2019 Measures

  HEDIS Measures Help Health Plans Improve Performance, Reduce Costs, and Streamline Workflow

  February 22, 2019

   · 

  3 min read
• Business

  WuXi STA and BioLingus sign exclusive technology and marketing collaboration for sublingual delivery

  STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec – and BioLingus, a Swiss biotech company, announce they have formed an exclusive technology and marketing collaboration for sublingual delivery.

  February 22, 2019

   · 

  3 min read
• Drug Development

  AlzProtect, on Track for a Phase 2 Entry in 2019, for its Drug Candidate AZP2006

  AlzProtect, a biopharmaceutical company engaged in the development of drugs for the treatment of Alzheimer’s disease and Progressive Supranuclear Palsy (PSP), announced today the successful completion of the latest phase 1 study regarding the effect of food intake for its drug candidate AZP2006.

  February 22, 2019

   · 

  3 min read
• Business

  WellCare Announces Appearances At Investor Conferences

  WellCare Health Plans, Inc. announced that members of its management team are scheduled to present at two upcoming conferences in March 2019.

  February 22, 2019

   · 

  1 min read
• Policy

  Dexcom G6® CGM System Receives Health Canada Approval

  Dexcom, Inc., a leader in continuous glucose monitoring, announced that the company has received Health Canada approval for its next generation Dexcom G6 CGM System for people with diabetes ages two years and up.

  February 22, 2019

   · 

  4 min read